Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kenvue
Marketing
NAD reaches split decision on Kenvue-Hims & Hers hair ad row
The NAD delivered a mixed verdict, telling Hims & Hers Health to change certain claims while dismissing other challenges brought by Kenvue.
Nick Paul Taylor
Aug 25, 2026 3:38am
Troubled Kenvue sells itself to Kimberly-Clark in $48.7B buyout
Nov 3, 2025 11:51am
Texas AG sues Kenvue over alleged Tylenol-autism link
Oct 28, 2025 1:16pm
Kenvue presses FDA to keep Tylenol safety label as is
Oct 21, 2025 12:04pm
RFK Jr. to link Tylenol use during pregnancy to autism: WSJ
Sep 5, 2025 3:00pm
Kenvue's strategic review stirs up CEO departure
Jul 15, 2025 11:22am